Mangalam Drugs & Organics has informed that the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (including their immediate relatives) from October 1, 2024 till the expiry of forty-eight (48) hours after the declaration of Unaudited Financial Results of the Company for the period ended September 30, 2024.
The above information is a part of company’s filings submitted to BSE.